Oncologists' experience with CGT has increased, with more patients treated and earlier lines of therapy being utilized.

Long-term follow-up shows 95% success rate, no serious complications in largest ADA-SCID gene therapy study to date ...

Cell and gene therapies (CGTs) are moving rapidly from specialist trials to routine care: more than thirty products are ...

Kadimastem enters strategic collaboration with TargetGene to advance next-generation gene-edited cell therapies: Zurich, Switzerland Tuesday, October 28, 2025, 13:00 Hrs [IST] NLS ...

Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

CARsgen Therapeutics Holdings Ltd. (($HK:2171)) announced an update on their ongoing clinical study. CARsgen Therapeutics Holdings Ltd. has ...

Thanks to in-utero blood transfusion technology, what was once a fatal diagnosis in the womb can now result in live births. However, this medical advancement created a new challenge: a growing ...

NLS Pharmaceutics ( ($NLSP) ) has provided an update. On October 27, 2025, NLS Pharmaceutics Ltd. announced a strategic collaboration between ...

Eli Lilly has agreed to acquire eye disease specialist Adverum Biotechnologies, bucking a recent trend of big pharma ...